Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00755469 · ClinicalTrials.gov registry record · NA
Post-conditioning to Reduce Infarct Size
A NA study, sponsored by Minneapolis Heart Institute Foundation.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
NCT00755469 is a NA study that has completed, run by Minneapolis Heart Institute Foundation. The registered enrollment target is 43 participants.
The verdict
NCT00755469, a NA study, has completed, sponsored by Minneapolis Heart Institute Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
Study Summary
When angioplasty (PTCA) and stenting of the blood vessels of the heart is the treatment for a Heart Attack, there is damage to the heart muscle that is caused by the sudden opening of the blood vessels. This is called "reperfusion injury". The cell death is due to inflammation and the generation of free radicals. The primary objective of this study is to determine if post-conditioning(four brief (30 second) PTCA balloon inflations) reduces damage to the heart muscle. This will be measured by heart enzyme tests-CK measurements- and by cardiac MRI.
Interventions
- PROCEDURE Post-conditioning
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2008-09 |
| Est. Completion | 2010-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00755469
The ClinicalTrials.gov registry entry for NCT00755469 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Minneapolis Heart Institute Foundation, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Post-conditioning is the first listed.
NCT00755469 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00755469 about?
NCT00755469 is a clinical study titled "Post-conditioning to Reduce Infarct Size". When angioplasty (PTCA) and stenting of the blood vessels of the heart is the treatment for a Heart Attack, there is damage to the heart muscle that is caused by the sudden opening of the blood vessels. This is called "reperfusion injury". The cell death is due to inflammation and the generation of ...
What is the current status of trial NCT00755469?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2008-09. Estimated completion is 2010-08.
What interventions are being tested in trial NCT00755469?
The interventions under investigation include: Post-conditioning (PROCEDURE).
Who is sponsoring clinical trial NCT00755469?
This trial is sponsored by Minneapolis Heart Institute Foundation, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.